#liver cancer

A majority of people with alcohol-related liver cirrhosis may have normal ALT levels.

Abdominal obesity worsened the impact of air pollution on MAFLD development.

The PreHevbrio vaccine produces higher antibody levels and offers faster protection.

People with fatty liver disease and obesity who underwent bariatric surgery had better clinical outcomes.

Over the next two decades, obesity-linked NASH will lead to more deaths and high cost in the United States.

From 1995 to 2016, hepatocellular carcinoma incidence in rural populations climbed by 218%.

People under 50 who were cured of hepatitis C were at comparable risk to the general population.

Barriers still stand in the way of making treatment available to all who need it.

But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.

Disruptions in access to treatment and harm reduction services could set back effort to eliminate hep C in the U.S.

An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.

The early cancer is detected, the easier it is to treat.

Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.

Current screening guidelines may shortchange Black individuals.

The disease has similar prevalence across high-income and low- and middle-income nations.

Mice that performed modest exercise were less likely to show signs of inflammation, cell aging and liver cancer.